Recent reports suggest that high-dose IL-10 treatment may not lead to the expected therapeutic outcome, raising the question of whether IL-10 has dose-dependent effects for enhancing cardiac tissue repair after MI, or even unexpected side effects from overdosing. The gene discussed is IL10; the disease is myocardial infarction.